JAZZ vs KALA · P/E 1988, rev $2.28B vs $54.3M cap
Jazz Pharmaceuticals PLC (JAZZ) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. KALA currently screens at market cap $54.3M.
Not investment advice. Open the JAZZ and KALA stock pages for the full models.
Not investment advice.